The invention describes peptide analogues of a-melanocyte-stimulating hormone (a-MSH), which posses an increased efficacy compared to the native .alpha.-MSH peptide. The .alpha.-MSH analogues exhibit increased anti-inflammatory effects and increased capability to prevent ischemic conditions compared to .alpha.-MSH. The invention further discloses use of the peptides for the manufacture of pharmaceutical compositions for the treatment or prophylaxis of a condition in the tissue of one or more organs of a mammal, and moreover pharmaceutical compositions.

 
Web www.patentalert.com

< METHODS AND COMPOSITIONS FOR TREATING CONDITIONS

> Inhibitors of Histone Deacetylase

> Use Of Urokinase Inhibitors for the Treatment and/or Prevention of Neuropathological Diseases

~ 00503